2-(1H-imidazol-3-ium-3-yl)-1-phenylethanone

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(1H-imidazol-3-ium-3-yl)-1-phenylethanone
• 化学式: C11H11N2O+
• 分子量: 187.22
• InChiKey: CVJNXVLQSKPUGP-UHFFFAOYSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  36.7
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• Process for the Photoactivation and use of a Catalyst by an Inverted Two-Stage Procedure
  申请人：Benkhoff Johannes

  公开号：US20070249484A1

  公开（公告）日：2007-10-25

  The invention pertains to a process for the application of a specific photolatent catalyst (a) wherein a composition of matter, comprising said catalyst, is subjected to irradiation before being further processed.

  本发明涉及一种特定光潜催化剂（a）的应用过程，其中包含该催化剂的物质组成被辐照后再进行进一步加工。
• COMPOSITIONS FOR CANCER TREATMENT
  申请人：Engene, Inc.

  公开号：EP1556088A2

  公开（公告）日：2005-07-27
• Cancer treatment by metabolic modulations
  申请人：Pownall Scott

  公开号：US20050202559A1

  公开（公告）日：2005-09-15

  The invention provides compositions and methods for inhibiting the growth or proliferation of hyperproliferative cells or inducing regression of hyperproliferative cells. More specifically, the invention provides compositions and methods for stimulating glycogen accumulation in target cells (e.g., hyperproliferative cells) in order to increase glycogen to a level that is toxic to the target cell.
• CANCER TREATMENT BY METABOLIC MODULATIONS
  申请人：POWNALL SCOTT

  公开号：US20090041740A1

  公开（公告）日：2009-02-12

  The invention provides compositions and methods for inhibiting the growth or proliferation of hyperproliferative cells or inducing regression of hyperproliferative cells. More specifically, the invention provides compositions and methods for stimulating glycogen accumulation in target cells (e.g., hyperproliferative cells) in order to increase glycogen to a level that is toxic to the target cell.
• [EN] CANCER TREATMENT BY METABOLIC MODULATIONS<br/>[FR] TRAITEMENT DE CANCER PAR DES MODULATIONS METABOLIQUES
  申请人：ENGENE INC

  公开号：WO2004039412A2

  公开（公告）日：2004-05-13

  The invention provides compositions and methods for inhibiting the growth or proliferation of hyperproliferative cells or inducing regression of hyperproliferative cells. More specifically, the invention provides compositions and methods for stimulating glycogen accumulation in target cells (e.g., hyperproliferative cells) in order to increase glycogen to a level that is toxic to the target cell.